Skip to content
healthcare.dev

Oxcarbazepine

NDC 10135-798, Oxcarbazepine, suspension, from Marlex Pharmaceuticals, Inc.

Product NDC
10135-798
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217782
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-798 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE300 mg/5mL

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
10135-798-4110135079841250 mL in 1 BOTTLE, GLASS (10135-798-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d3684d55-0564-4849-bdf6-b91f22a3e28c

Use it

Look up 10135-798 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-798 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-798. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.